These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Evaluation of the serum level of total immunoglobulins E during allergic-immunological diseases of the eye]. Bloch-Michel E; Cartron JP; Herman D; Campinchi R Arch Ophtalmol Rev Gen Ophtalmol; 1973; 33(8):565-72. PubMed ID: 4272349 [No Abstract] [Full Text] [Related]
5. Immunoglobulins: structure, function and relation to the eye. Allansmith MR; O'Connor GR Surv Ophthalmol; 1970 Mar; 14(5):367-402. PubMed ID: 4193209 [No Abstract] [Full Text] [Related]
6. Quantitative determinations of complement components and immunoglobulins in tears and aqueous humor. Chandler JW; Leder R; Kaufman HE; Caldwell JR Invest Ophthalmol; 1974 Feb; 13(2):151-3. PubMed ID: 4204497 [No Abstract] [Full Text] [Related]
7. [Bactericidal and lysozyme activity of the blood in gonorrhea]. Krasil'nikov AP; Fedorova LG; Kaskevich LI; Kun'ko TD Vestn Dermatol Venerol; 1981 Mar; (3):41-6. PubMed ID: 7257596 [No Abstract] [Full Text] [Related]
8. [Various indicators of natural humoral immunity in acute pneumonia]. Veselov BV; Iaglinskaia AV; Boguslavskaia MI; Shevel' EIa; Elmanova LI Ter Arkh; 1981; 53(3):70-3. PubMed ID: 6789487 [No Abstract] [Full Text] [Related]
9. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Chang JH; McCluskey PJ; Wakefield D Br J Ophthalmol; 2006 Jan; 90(1):103-8. PubMed ID: 16361678 [TBL] [Abstract][Full Text] [Related]
10. [Indicators of nonspecific immunity in purulent infection in diabetes mellitus]. Nuzov BG Sov Med; 1985; (1):80-3. PubMed ID: 3983688 [No Abstract] [Full Text] [Related]
11. [Use of prodigiozan in the complex therapy of burns]. Golosova TV; Murashova NS; Gorbuntsova RV; Gerasimova LI Antibiotiki; 1971; 16(8):757-61. PubMed ID: 4945153 [No Abstract] [Full Text] [Related]
12. [The anti globulin consumption test (AGC-test) in inflammatory and non inflammatory eye diseases]. Kühl W; Schröder KD Klin Monbl Augenheilkd; 1971 Mar; 158(3):379-83. PubMed ID: 5573458 [No Abstract] [Full Text] [Related]
13. [Changes in various indices of natural resistance in syphilis patients during treatment]. Esenin AA Vestn Dermatol Venerol; 1983 Mar; (3):68-70. PubMed ID: 6858377 [No Abstract] [Full Text] [Related]
14. Mechanisms of the host response in the eye. II. Variations in ocular disease produced by several different antigens. Aronson SB; Martenet AC; Yamamoto EA; Bedford MJ Arch Ophthalmol; 1966 Aug; 76(2):266-73. PubMed ID: 5945179 [No Abstract] [Full Text] [Related]
15. [11-beta-hydroxy-6-alpha-methyl-progesterone (a new synthetic corticosteroid with an anti-inflammatory effect and no ocular hypertensive action)]. Palmieri L; Mazzilli G Ann Ottalmol Clin Ocul; 1968 Oct; 94(10):1295-304. PubMed ID: 5733457 [No Abstract] [Full Text] [Related]
16. [The healing effect of extracorporeal circulation]. Shevchenko IuL; Matveev SA; Kucherenko AD; Zhuravlev VP Vestn Khir Im I I Grek; 1992 Jun; 148(6):258-63. PubMed ID: 1302967 [No Abstract] [Full Text] [Related]
17. [Immunology in clinical practice. XIII. Immune diseases of the eye]. Ooijman FM; van der Lelij A Ned Tijdschr Geneeskd; 1998 Feb; 142(9):443-8. PubMed ID: 9562756 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of immunogenic disease. Turk J Trans Ophthalmol Soc U K (1962); 1971; 91():449. PubMed ID: 5291540 [No Abstract] [Full Text] [Related]
20. Allergic disease of the outer eye. Jones BR Trans Ophthalmol Soc U K (1962); 1971; 91():441-7. PubMed ID: 4259756 [No Abstract] [Full Text] [Related] [Next] [New Search]